149 related articles for article (PubMed ID: 33216241)
1. Value of Plasma Methylated SFRP2 in Prognosis of Gastric Cancer.
Yan H; Chen W; Ge K; Mao X; Li X; Liu W; Wu J
Dig Dis Sci; 2021 Nov; 66(11):3854-3861. PubMed ID: 33216241
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Plasma-Methylated
Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S
Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490
[TBL] [Abstract][Full Text] [Related]
3. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
5. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer.
Bi Y; Zhang J; Zeng D; Chen L; Ye W; Yang Q; Ling Y
Pathol Oncol Res; 2021; 27():580800. PubMed ID: 34257526
[No Abstract] [Full Text] [Related]
7. Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer.
Zhang X; Zhang X; Sun B; Lu H; Wang D; Yuan X; Huang Z
Oncol Lett; 2014 Oct; 8(4):1745-1750. PubMed ID: 25202403
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
[TBL] [Abstract][Full Text] [Related]
9. Secreted Frizzled-Related Protein 2 Is Associated with Disease Progression and Poor Prognosis in Breast Cancer.
Huang C; Ye Z; Wan J; Liang J; Liu M; Xu X; Li L
Dis Markers; 2019; 2019():6149381. PubMed ID: 30944668
[TBL] [Abstract][Full Text] [Related]
10. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
11. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
[TBL] [Abstract][Full Text] [Related]
12. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
13. Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum.
Li H; Wang Z; Zhao G; Ma Y; Chen Y; Xue Q; Zheng M; Fei S
Int J Biol Markers; 2019 Mar; 34(1):54-59. PubMed ID: 30852954
[TBL] [Abstract][Full Text] [Related]
14. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
Li Y; Peng Z; Zhang X; Gong J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
16. Methylation status and long-fragment cell-free DNA are prognostic biomarkers for gastric cancer.
Ko K; Kananazawa Y; Yamada T; Kakinuma D; Matsuno K; Ando F; Kuriyama S; Matsuda A; Yoshida H
Cancer Med; 2021 Mar; 10(6):2003-2012. PubMed ID: 33641249
[TBL] [Abstract][Full Text] [Related]
17. LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes
Byun HJ; Yoon JH; Lee SK
Yonsei Med J; 2020 Nov; 61(11):923-934. PubMed ID: 33107235
[TBL] [Abstract][Full Text] [Related]
18. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
19. Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.
Han J; Lv P; Yu JL; Wu YC; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Dig Dis Sci; 2014 Jun; 59(6):1160-8. PubMed ID: 24385013
[TBL] [Abstract][Full Text] [Related]
20. Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M; Usul Afsar C; Serimez M; Karabulut S
J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
